Selected research
Industry Research
Automatic Insulin Dose Adjustment Software Industry Research Report 2026
Market perspective
The global Automatic Insulin Dose Adjustment Software market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the Automatic Insulin Dose Adjustment Software market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Automatic Insulin Dose Adjustment Software market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Automatic Insulin Dose Adjustment Software market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Automatic Insulin Dose Adjustment Software include Glytec, Beta Bionics, Hygieia, Tandem Diabetics, CamDiab, Medtronic, Novo Nordisk, Omnipod and Tempo Platform. among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global Automatic Insulin Dose Adjustment Software market in terms of revenue (US$ million) and, where applicable, service volume (k units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Automatic Insulin Dose Adjustment Software.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Automatic Insulin Dose Adjustment Software Market by Company
Glytec
Beta Bionics
Hygieia
Tandem Diabetics
CamDiab
Medtronic
Novo Nordisk
Omnipod
Tempo Platform
Automatic Insulin Dose Adjustment Software Segment by Type
Open-Loop Systems
Closed-Loop Systems
Automatic Insulin Dose Adjustment Software Segment by Application
Subscription Used
One-time Purchase Used
Automatic Insulin Dose Adjustment Software Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Automatic Insulin Dose Adjustment Software market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Automatic Insulin Dose Adjustment Software and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Automatic Insulin Dose Adjustment Software.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Automatic Insulin Dose Adjustment Software companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Open-Loop Systems
- Closed-Loop Systems
Applications
- Subscription Used
- One-time Purchase Used
Companies covered
- Glytec
- Beta Bionics
- Hygieia
- Tandem Diabetics
- CamDiab
- Medtronic
- Novo Nordisk
- Omnipod
- Tempo Platform
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Automatic Insulin Dose Adjustment Software by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Open-Loop Systems
- 2.2.3 Closed-Loop Systems
- 2.3 Automatic Insulin Dose Adjustment Software by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Subscription Used
- 2.3.3 One-time Purchase Used
- 2.4 Assumptions and Limitations
3 Automatic Insulin Dose Adjustment Software Breakdown Data by Type
- 3.1 Global Automatic Insulin Dose Adjustment Software Historic Market Size by Type (2021-2026)
- 3.2 Global Automatic Insulin Dose Adjustment Software Forecasted Market Size by Type (2027-2032)
4 Automatic Insulin Dose Adjustment Software Breakdown Data by Application
- 4.1 Global Automatic Insulin Dose Adjustment Software Historic Market Size by Application (2021-2026)
- 4.2 Global Automatic Insulin Dose Adjustment Software Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Automatic Insulin Dose Adjustment Software Market Perspective (2021-2032)
- 5.2 Global Automatic Insulin Dose Adjustment Software Growth Trends by Region
- 5.2.1 Global Automatic Insulin Dose Adjustment Software Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Automatic Insulin Dose Adjustment Software Historic Market Size by Region (2021-2026)
- 5.2.3 Automatic Insulin Dose Adjustment Software Forecasted Market Size by Region (2027-2032)
- 5.3 Automatic Insulin Dose Adjustment Software Market Dynamics
- 5.3.1 Automatic Insulin Dose Adjustment Software Industry Trends
- 5.3.2 Automatic Insulin Dose Adjustment Software Market Drivers
- 5.3.3 Automatic Insulin Dose Adjustment Software Market Challenges
- 5.3.4 Automatic Insulin Dose Adjustment Software Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Automatic Insulin Dose Adjustment Software Players by Revenue
- 6.1.1 Global Top Automatic Insulin Dose Adjustment Software Players by Revenue (2021-2026)
- 6.1.2 Global Automatic Insulin Dose Adjustment Software Revenue Market Share by Players (2021-2026)
- 6.2 Global Automatic Insulin Dose Adjustment Software Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Automatic Insulin Dose Adjustment Software Head Office and Area Served
- 6.4 Global Automatic Insulin Dose Adjustment Software Players, Product Type & Application
- 6.5 Global Automatic Insulin Dose Adjustment Software Manufacturers Established Date
- 6.6 Global Automatic Insulin Dose Adjustment Software Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Automatic Insulin Dose Adjustment Software Market Size (2021-2032)
- 7.2 North America Automatic Insulin Dose Adjustment Software Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Automatic Insulin Dose Adjustment Software Market Size by Country (2021-2026)
- 7.4 North America Automatic Insulin Dose Adjustment Software Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Automatic Insulin Dose Adjustment Software Market Size (2021-2032)
- 8.2 Europe Automatic Insulin Dose Adjustment Software Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Automatic Insulin Dose Adjustment Software Market Size by Country (2021-2026)
- 8.4 Europe Automatic Insulin Dose Adjustment Software Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Automatic Insulin Dose Adjustment Software Market Size (2021-2032)
- 9.2 Asia-Pacific Automatic Insulin Dose Adjustment Software Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Automatic Insulin Dose Adjustment Software Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Automatic Insulin Dose Adjustment Software Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Automatic Insulin Dose Adjustment Software Market Size (2021-2032)
- 10.2 South America Automatic Insulin Dose Adjustment Software Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Automatic Insulin Dose Adjustment Software Market Size by Country (2021-2026)
- 10.4 South America Automatic Insulin Dose Adjustment Software Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Automatic Insulin Dose Adjustment Software Market Size (2021-2032)
- 11.2 Middle East & Africa Automatic Insulin Dose Adjustment Software Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Automatic Insulin Dose Adjustment Software Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Automatic Insulin Dose Adjustment Software Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 Glytec
- 12.1.1 Glytec Company Information
- 12.1.2 Glytec Business Overview
- 12.1.3 Glytec Revenue in Automatic Insulin Dose Adjustment Software Business (2021-2026)
- 12.1.4 Glytec Automatic Insulin Dose Adjustment Software Product Portfolio
- 12.1.5 Glytec Recent Developments
- 12.2 Beta Bionics
- 12.2.1 Beta Bionics Company Information
- 12.2.2 Beta Bionics Business Overview
- 12.2.3 Beta Bionics Revenue in Automatic Insulin Dose Adjustment Software Business (2021-2026)
- 12.2.4 Beta Bionics Automatic Insulin Dose Adjustment Software Product Portfolio
- 12.2.5 Beta Bionics Recent Developments
- 12.3 Hygieia
- 12.3.1 Hygieia Company Information
- 12.3.2 Hygieia Business Overview
- 12.3.3 Hygieia Revenue in Automatic Insulin Dose Adjustment Software Business (2021-2026)
- 12.3.4 Hygieia Automatic Insulin Dose Adjustment Software Product Portfolio
- 12.3.5 Hygieia Recent Developments
- 12.4 Tandem Diabetics
- 12.4.1 Tandem Diabetics Company Information
- 12.4.2 Tandem Diabetics Business Overview
- 12.4.3 Tandem Diabetics Revenue in Automatic Insulin Dose Adjustment Software Business (2021-2026)
- 12.4.4 Tandem Diabetics Automatic Insulin Dose Adjustment Software Product Portfolio
- 12.4.5 Tandem Diabetics Recent Developments
- 12.5 CamDiab
- 12.5.1 CamDiab Company Information
- 12.5.2 CamDiab Business Overview
- 12.5.3 CamDiab Revenue in Automatic Insulin Dose Adjustment Software Business (2021-2026)
- 12.5.4 CamDiab Automatic Insulin Dose Adjustment Software Product Portfolio
- 12.5.5 CamDiab Recent Developments
- 12.6 Medtronic
- 12.6.1 Medtronic Company Information
- 12.6.2 Medtronic Business Overview
- 12.6.3 Medtronic Revenue in Automatic Insulin Dose Adjustment Software Business (2021-2026)
- 12.6.4 Medtronic Automatic Insulin Dose Adjustment Software Product Portfolio
- 12.6.5 Medtronic Recent Developments
- 12.7 Novo Nordisk
- 12.7.1 Novo Nordisk Company Information
- 12.7.2 Novo Nordisk Business Overview
- 12.7.3 Novo Nordisk Revenue in Automatic Insulin Dose Adjustment Software Business (2021-2026)
- 12.7.4 Novo Nordisk Automatic Insulin Dose Adjustment Software Product Portfolio
- 12.7.5 Novo Nordisk Recent Developments
- 12.8 Omnipod
- 12.8.1 Omnipod Company Information
- 12.8.2 Omnipod Business Overview
- 12.8.3 Omnipod Revenue in Automatic Insulin Dose Adjustment Software Business (2021-2026)
- 12.8.4 Omnipod Automatic Insulin Dose Adjustment Software Product Portfolio
- 12.8.5 Omnipod Recent Developments
- 12.9 Tempo Platform
- 12.9.1 Tempo Platform Company Information
- 12.9.2 Tempo Platform Business Overview
- 12.9.3 Tempo Platform Revenue in Automatic Insulin Dose Adjustment Software Business (2021-2026)
- 12.9.4 Tempo Platform Automatic Insulin Dose Adjustment Software Product Portfolio
- 12.9.5 Tempo Platform Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst